UnitedHealth (UNH) Ceo, Uhc Noel Timothy John Buys 76 Shares

Executive Insider Buying at UnitedHealth Group

Noel Timothy John, Chief Executive Officer, UHC at UnitedHealth Group Incorporated (NYSE: UNH), acquired 76 shares of company stock on June 23, 2026. The transaction added to the executive's stake in the healthcare provider without a reported price attached to the filing. Insiders often pick up shares for various personal financial reasons, and this filing forms part of a broader set of transactions recorded by company leaders on the exact same date.

Multiple Insiders Add to Positions

Several other leaders at UnitedHealth Group also reported share acquisitions on June 23, 2026. Dennis Andrew Stankiewicz, Chief Accounting Officer, picked up 51 shares, while Patrick Hugh Conway, Chief Executive Officer of Optum, bought 83 shares. Additional buying activity on that date included 8 shares acquired by Kristen Gil, 3 shares by Scott Gottlieb, 41 shares by John Noseworthy, and 41 shares by Valerie Md Montgomery Rice. None of these transactions were reported as part of a pre-arranged Rule 10b5-1 trading plan.

Stock Price Context and Trading Range

UnitedHealth shares recently changed hands at $415.53. The equity has tracked within a 52-week band spanning from a low of $255.97 up to a high of $461.62. Moving averages show the stock trading above its 50-day marker of $387.35 and its 200-day measure of $358.75. The company carries a forward P/E ratio of 17.55 alongside a trailing P/E of 26.15.

Analysts Set New Price Targets

Wall Street firms have continued to adjust their outlooks on the healthcare provider through October 2026. On October 16, Bernstein maintained its outperform rating while tweaking its price target to $500.00 from $512.00. On the same day, JP Morgan kept an overweight rating and raised its target to $524.00 from $516.00. Earlier in October, TD Cowen maintained a hold rating with a $402.00 target, Piper Sandler kept an overweight stance with a $504.00 target, Barclays maintained an overweight rating at a $440.00 target, and Baird kept a neutral rating with a $427.00 target. Across 25 analyst opinions, the stock holds a consensus buy recommendation with a mean price target of $477.04.

Company Background and Outlook

Based in Eden Prairie, Minnesota, UnitedHealth Group operates as a diversified healthcare company offering health benefits and care delivery services through segments like UnitedHealthcare and Optum. The firm employs roughly 390,000 people and manages a sprawling network spanning insurance plans, pharmacy care services, and health data solutions.

Observers will monitor upcoming corporate updates and financial disclosures as the company approaches its next scheduled earnings report on January 26, 2027. Insiders filing transaction forms provide a look into executive activity, though these records reflect past choices rather than direct guidance on future market movements.